Related Experiment Video
Updated: Jul 13, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models
Günter Fingerle-Rowson1, Oleksi Petrenko
1University Hospital Cologne, Clinic I of Internal Medicine, Dept. of Hematology and Oncology, Cologne, Germany. g.fingerle-rowson@gmx.de
Abstract:
Macrophage migration inhibitory factor (MIF) is a ubiquitously expressed pro-inflammatory mediator that has also been implicated in the process of oncogenic transformation and tumor progression. We used a genetic approach to show that deletion of the MIF gene in mice has several major consequences for the proliferative and transforming properties of cells. MIF-deficient cells exhibit increased resistance to oncogenic transformation. The transformation defects associated with MIF deficiency can be overcome through concomitant inactivation of the p53 and Rb/E2F tumor suppressor pathways. We have produced compelling evidence that the effects of MIF on cell survival and tumorigenesis are mediated through overlapping pathways, wherein MIF and p53 functionally antagonize each other in the cell. However, the involvement of MIF in p53 function is secondary to p53-independent mechanisms controlling protein stability, DNA damage checkpoints, and the integrity of the genome. Given the broad spectrum of cell types that normally express MIF and its elevated levels at sites of chronic inflammation, this pathway may be generic for many early stage tumors.
Insights
Macrophage migration inhibitory factor (MIF) deficiency in mice increases resistance to cancer development. MIF and p53 pathways interact, suggesting MIF’s role in early-stage tumors.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Macrophage migration inhibitory factor (MIF) is a pro-inflammatory mediator implicated in cancer.
- MIF's role in oncogenic transformation and tumor progression requires further elucidation.
Purpose of the Study:
- To investigate the consequences of MIF gene deletion on cellular proliferation and transformation.
- To explore the interplay between MIF, p53, and Rb/E2F pathways in tumorigenesis.
Main Methods:
- Genetic deletion of the MIF gene in mice.
- Analysis of cellular transformation properties in MIF-deficient cells.
- Investigation of functional antagonism between MIF and p53.
Main Results:
- MIF-deficient cells show increased resistance to oncogenic transformation.
- Inactivation of p53 and Rb/E2F pathways can overcome MIF deficiency-related transformation defects.
- MIF and p53 functionally antagonize each other, influencing cell survival and tumorigenesis via overlapping pathways.
- MIF's impact on p53 function is secondary to p53-independent mechanisms regulating genomic integrity.
Conclusions:
- MIF plays a significant role in cellular transformation and tumor progression.
- The MIF-p53 interaction is a critical pathway in cancer development.
- MIF's involvement in p53-independent mechanisms highlights its broad impact on genomic stability.
- Targeting MIF may offer a therapeutic strategy for early-stage tumors, particularly those with chronic inflammation.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System

